4528 POSTER Upfront medical management of clinical stage (CS) I–IIA testicular cancer patients with embryonal carcinoma predominance and/or lymphovascular invasion

F.El Karak; C.Salas; M.Rivoire; J.P.Droz; A.Flechon

首页> 外文期刊>European Journal of Cancer Supplements >4528 POSTER Upfront medical management of clinical stage (CS) I–IIA testicular cancer patients with embryonal carcinoma predominance and/or lymphovascular invasion

【24h】

4528 POSTER Upfront medical management of clinical stage (CS) I–IIA testicular cancer patients with embryonal carcinoma predominance and/or lymphovascular invasion

机译：4528 POSTER临床期（CS）I–IIA期睾丸癌合并胚胎癌占优势和/或淋巴管浸润的患者的前期医疗管理

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2007年第4期| 共1页
作者
F.El Karak; C.Salas; M.Rivoire; J.P.Droz; A.Flechon;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献

1. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J, Department of Urology, Sidney [J] . Rowland RG Urologic oncology . 2006 ,第2期

机译：具有胚胎癌优势和/或淋巴管浸润的低度睾丸癌患者的腹膜后淋巴结清扫Stephenson AJ，Bosl GJ，Bajorin DF，Stasi J，Motzer RJ，Sheinfeld J，泌尿外科，悉尼
2. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion [J] . Lago-Hernandez C. A., Feldman H., ODonnell E., Annals of oncology: official journal of the European Society for Medical Oncology . 2015 ,第7期

机译：基于评估胚胎优势和淋巴管浸润的临床1期NSGCT的精细风险分层方案
3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion [J] . Lago-Hernandez C. A., Feldman H., ODonnell E., Annals of oncology: official journal of the European Society for Medical Oncology . 2015 ,第7期

机译：基于胚胎致力和淋巴血管侵袭的评估，对临床阶段1 NSGCT的精细风险分层方案
4. Pain is a prognostic factor in association with cancer growth pattern and clinical stage in patients with oral squamous cell carcinoma [C] . Sato J, Yamazaki Y, Satoh A, European Association of Cranio-Maxillo-Facial Surgery . 2010

机译：疼痛是与口腔鳞状细胞癌患者癌症生长模式和临床阶段相关的预后因素
5. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion [O] . C. A. Lago-Hernandez, H. Feldman, E. ODonnell, -1

机译：基于评估胚胎优势和淋巴管浸润的临床1期NSGCT的精细风险分层方案
6. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion [O] . Lago-Hernandez C., Feldman H., ODonnell E., 2015

机译：基于胚胎优势和淋巴血管侵犯评估的临床1期NsGCT的精细风险分层方案

4528 POSTER Upfront medical management of clinical stage (CS) I–IIA testicular cancer patients with embryonal carcinoma predominance and/or lymphovascular invasion

著录项

相似文献

相关主题

期刊订阅